From January 1, 2023 to February 2, 2023, the company has repurchased 22,972 shares, representing 0.007245% for CNY 1.67 million. With this, the company has completed the repurchase of 1,459,586 shares, representing 0.46% for CNY 99.69 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.2 CNY | -1.38% |
|
-1.01% | -8.19% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.19% | 1.64B | |
+3.06% | 210B | |
+7.88% | 186B | |
+31.45% | 158B | |
+33.07% | 113B | |
+2.28% | 66.13B | |
+21.32% | 56.25B | |
+0.11% | 49B | |
-7.03% | 38.16B | |
+0.22% | 35.98B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.